OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Peripheral Sensorimotor Neuropathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,223 reports · 52 co-occurring drugs

As of the last recalculation, Peripheral Sensorimotor Neuropathy appears in 1,223 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 75.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Brentuximab Vedotin4475.776.1
Epoetin Alfa2536.636.7
Amiodarone Hydrochloride2335.635.7
Ado-Trastuzumab Emtansine1734.834.9
Bleomycin Sulfate1626.726.7
Risedronate Sodium4626.126.2
Bortezomib11123.123.2
Rosuvastatin Calcium3622.422.4
Vincristine Sulfate2917.217.2
Amlodipine Besylate And Valsartan1117.117.1
Piperacillin Sodium,Tazobactam Sodium2516.416.4
Melphalan2116.016.0
Melphalan Hydrochloride2215.215.2
Piperacillin And Tazobactam1114.814.8
Pertuzumab2314.714.7
Cenobamate714.414.4
Pramipexole1213.413.5
Metronidazole Topical3512.812.8
Zoledronic Acid2912.612.6
Vancomycin Hydrochloride4612.312.3
Etoposide5012.012.0
Daratumumab2711.711.7
Leucovorin Calcium1311.711.7
Doxorubicin5811.611.6
Azacitidine For1211.311.3
Thalidomide2411.311.3
Tamsulosin Hydrochloride1310.911.0
Polatuzumab Vedotin610.510.5
Oxaliplatin4310.210.2
Cyclophosphamide Injection, Solution9710.010.0
Cyclophosphamide9710.010.0
Cyclophosphamide For Injection9710.010.0
Doxorubicin Hydrochloride189.59.5
Vigabatrin89.49.4
Bupivacaine59.19.1
Dexamethasone 1.5 Mg1399.09.0
Fluorouracil Cream, 0.5%399.09.0
Dexamethasone1398.98.9
Fluorouracil398.88.8
Pemetrexed118.88.8
Encorafenib58.68.6
Trastuzumab328.18.1
Paclitaxel (Aibumin-Bound)388.18.1
Ixazomib137.87.8
Bendamustine Hcl77.77.7
Azacitidine137.57.5
Paclitaxel407.17.1
Carboplatin496.86.8
Irinotecan Hydrochloride56.66.6
Panitumumab66.56.5
Ipilimumab145.65.6
Atezolizumab114.94.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.